Pillarsetty et al. demonstrate the ability to visualize the epichaperome, a pathologic protein-protein interaction network, and to measure inhibitor engagement from mice and patients at single-tumor resolution in real time, which facilitates the optimization of dose and schedule selection.
from Cancer Cell https://ift.tt/32FHoKO
from Cancer Cell https://ift.tt/32FHoKO